Skip to main content

Closed

INKT: MiNK Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-415.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio1.38×

MiNK Therapeutics, Inc.

INKTNASDAQ Capital Market·USD·Closed

MiNK Therapeutics, Inc.

INKTNASDAQ·USD·Closed

$10.50

−0.85%

$10.50

−$0.09 (0.85%)

52W Range

21thpctl

Volume

0.12×avg

Mkt Cap

52.31MUSD

P/E

-3.7TTM

Div Yield

–ann

52W Range

21thpctl

Volume

0.12×avg

Market Cap

52.31MUSD

P/E Ratio

-3.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings